<DOC>
	<DOCNO>NCT00301405</DOCNO>
	<brief_summary>To determine efficacy thalidomide treatment Chronic Pelvic Pain Syndrome ( CPPS ) .</brief_summary>
	<brief_title>Open-Label Study Thalidomide Chronic Prostatitis/Chronic Pelvic Pain</brief_title>
	<detailed_description>Prostatitis common urologic diagnosis men age 50 third common diagnosis old men . In Chronic Prostatitis ( CP ) Chronic Pelvic Pain Syndrome ( CPPS ) , men low urinary tract symptom , pelvic pain , sexual dysfunction decrease quality life . Little known cause CP/CPPS definitive therapy exists . Thalidomide immunomodulator ( drug alters immune system ) may also interfere development tiny blood vessel help support tumor growth . Therefore , theory , may reduce prevent growth cancer cell . Thalidomide approve Food Drug Administration ( FDA ) leprosy skin condition , treatment CP CPPS .</detailed_description>
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Prostatitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>1 . Male subject age 18 old . 2 . Male subject least 3 month symptom CP/CPPS refractory therapy 3 . Subjects minimum score 15 CPSI . 4 . Male subject must give write informed consent . 5 . Male subject must willing able comply recent version FDAmandated S.T.E.P.S.â Program include : He understand reliably carry instruction . He capable comply mandatory contraceptive measure appropriate male patient registration , patient survey describe S.T.E.P.S.â program . He receive oral write warning hazard take thalidomide expose fetus drug He receive oral write warn risk possible contraception failure presence thalidomide semen . He instruct must always use late condom sexual contact woman childbearing potential , even undergone successful vasectomy . He acknowledge write understand warn need use latex condom sexual contact woman childbearing potential , even undergone successful vasectomy . He agree NOT sperm blood donor treat thalidomide 1 . Subjects female . 2 . Subjects document positive urine culture ( &gt; 100,000 CFU/mL ) within past six month 3 . Subjects duration symptom less three month 4 . Subjects active genital infection 5 . Subjects prior urologic surgery 6 . Subjects know active prior genitourinary cancer include renal , ureteral , bladder prostate 7 . Subjects receive prior radiation abdominal pelvic area 8 . Subjects know bladder ureteral calculus 9 . Subjects unable complete void diary 10 . Subjects diagnose neuropathy 11 . Subjects neutropenia 12 . Subjects history deep venous thrombosis , pulmonary embolism , hypercoagulable state 13 . Any patient willing comply recent version FDAmandated S.T.E.P.Sâ program 14 . Subjects orthostatic hypotension 15 . Subjects know malignancy last 2 year .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>prostatitis</keyword>
	<keyword>pelvic pain</keyword>
</DOC>